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EFFECTS OF GENERAL INCIDENCE AND POLYMER JOINING
ON NUCLEATED POLYMERIZATION IN A MODEL OF PRION
PROLIFERATION*

MEREDITH L. GREERt, P. VAN DEN DRIESSCHE*, LIN WANG§, AN

Abstract. Two processes are incorporated into a new model for transmissi
These are general incidence for the lengthening process of infectious polym
converting noninfectious monomers, and the joining of two polymers to for
The model gives rise to a system of three ordinary differential equations, whi
threshold behavior dependent on the value of the parameter combination givin
tion number 1Zo. For Ko < 1, infectious polymers die out, whereas for Kq >
asymptotic to a positive disease equilibrium. The effect of both general inci
decrease the equilibrium value of infectious polymers and to increase the equili
monomers. Since the onset of disease symptoms appears to be related to the
polymers, both processes may significantly inhibit the course of the disease. W
the equilibrium distribution of polymer lengths is obtained and shows a sharp
to the distribution resulting from mass action incidence. Qualitative global resu
and disease equilibria are proved analytically. Numerical simulations using p
experiments on mice (reported in the literature) provide quantitative demonstr
these two processes.
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1. Introduction. Prion diseases, though widely studied at many levels, continue
to challenge understanding. A prion is an infectious protein. Several prion diseases
are known, or suspected, to be transmissible, both via ingestion and iatrogenically;
as a group, they are thus referred to as transmissible spongiform encephalopathies
(TSEs). Examples include scrapie, which affects sheep and goats; bovine spongiform
encephalopathy (BSE), which affects cows; chronic wasting disease (CWD), which
affects mule deer and elk; and variant Cruetzfeldt- Jakob disease (vCJD), which affects

humans [8, 9]. Additionally, mice and hamsters in laboratory experiments can be
infected with scrapie [30].
Though incidence of vCJD in humans has declined to just a few new cases per
year [36] and BSE incidence also appears to be declining [23], prion diseases warrant
ongoing study for reasons that include the following. First, there may be previously
unrecognized routes of infection: new research shows that prions can bind to some
soils and cause infection via inoculation with those soils [17], indicating that graz* Received by the editors May 24, 2006; accepted for publication (in revised form) June 6, 2007;
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ing animals may acquire TSEs despite having safely prepared feed. Seco
are extremely difficult to destroy, remaining infective despite heat or ra
would inactivate other known infectious agents [1, 5]. Third, prion replic
a new frontier in scientific understanding: protein-only replication canno
nucleic acids, but must occur somehow for TSEs to spread. Comprehendi
replication works may provide great insight to other biological processes.
A specific naturally occurring protein is vulnerable to infection by p
therefore known as prion protein. In its noninfectious form prion protei
by PrPc, and in its infectious form it is denoted by PrPSc; see, for exa
for discussion of this notation. The forms differ only in the folding of

[27]. Humans, cows, sheep, and other animals susceptible to TSEs pr

normally [4]. There is evidence both that an accumulation of PrPSc may
[24, 21] and that a lack of PrPc may leave the brain overly susceptible to
Either or both of these may lead to symptoms associated with TSEs. In
transmissible prion disease, some portion of PrPSc is introduced into the
this PrPSc can cause more infectious protein to be made. Though the mec
such protein replication is not fully understood, nucleated polymerization
candidate [15, 18].
Nucleated polymerization involves PrPSc attaching to PrPc and conver
prpSc \Ymje proteins usually exist as individual units, also known as m
it appears that PrPSc benefits from aggregating in some way [11, 16]. A
confers greater stability, and may even be necessary to maintain the alt
tein folding. We assume within this paper that these aggregates have a l
[18, 26], and we typically refer to the aggregates as polymers. In our nuc
merization model, each polymer may attach at either end to a PrPc monom
converting it to the infectious form of PrPSc. Since the polymer has th
its length by one unit of protein, we refer to this process as lengthening
polymerization also involves polymer splitting. We assume a minimum via
length, so that when polymer splitting results in pieces below the minim
these pieces must break apart into their component units of PrPc. Addit
model includes polymer joining, in which two PrPSc polymers join togeth

one longer polymer.

Models of nucleated polymerization for PrPc monomers and PrPSc p
containing a discrete number of monomers are formulated and analyzed
[22]. Based on these, a model with continuous polymer length is introd

and further analyzed in [12, 14, 28]. All these models assume mass action incid

the lengthening process of infectious polymers attaching to PrPc units. W
this form of incidence in a way that reduces lengthening when the total
infectious protein becomes large in proportion to the number of polym
research [24] has indicated that only truncated forms of polymers are able to

this way; it is also possible that polymers within a specific range of lengt
to lengthen at the fastest rate, but that all polymers are capable of lengt

Our general incidence term captures these features by reducing the rate of le

when total PrPSc mass is large relative to the total number of PrPSc poly
is, we reduce the rate of lengthening as the average polymer length becom
In addition, our model is the first to include polymer joining. Joining is
the fact that large fibrils or aggregates of PrPSc are observed in late stag
[2, 10].
We start in section 2 by incorporating the processes of general incidence and polymer joining into an ordinary differential equation (ODE) for the number of monomers,
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coupled with a partial integrodifferential equation for the density of polymers depe
ing on polymer length. Under some assumptions, this system is converted to a syste

of three ODEs, which is analyzed in section 3. Numerical simulations for param
obtained from experimental data on mice [30] are presented in section 4, and

conclude in section 5 with a discussion.

2. Model formulation. A core model of nucleated polymerization exists in
[12, 13, 14, 28] with some extensions in [32]. We continue to use the same variables
and parameters and introduce two new parameters, u and r/, to account for general
incidence and polymer joining, respectively:
• V(t) is the number of PrPc monomers at time t\
• u(x, t) is the density of PrPSc polymers of length x at time t;
• xo is the lower bound for polymer length; that is, polymers have length x
with xo < x < oo;
• U(t) = f™ u(x, t)dx is the number of PrPSc polymers at time t\
• p(t) = f™ xi/(x, t)dx is the number of PrPSc monomers comprising polymers
at time t]

• W(t) = P(t) - xoU(t) is the number of PrPSc units not accounted for within
the minimal polymer lengths;
• A is the source rate for naturally produced PrPc monomers;
• 7 is the metabolic degradation rate for PrPc;
• r is a rate associated with lengthening of PrPSc polymers by attaching to and
converting PrPc monomers;
• uj is a parameter associated with polymer lengthening;
• /?(x) is the length-dependent rate of polymer breakage;
• k(x, y) is the probability, when a polymer of length y breaks, that one of the
two resulting polymers has length x;
• /x(x) is the length-dependent metabolic degradation rate of PrPSc polymers;
• rj is the rate at which PrPSc polymers join together.
All parameters are assumed to be positive with the exception of u and 77, which
may also be zero.

2.1. PDE model. Our model, incorporating both general incidence and polymer joining into the model formulated and discussed in [12, 13, 14, 28], has monomer
dynamics governed by

(2.1) V'(t) = \-<yV(t)- 1 + 1" u)P(t)
+ u)P(t)
)>+2
JoJo
JXo
x JXo P(y)K(x,y)u(y,t)dydx
with V'(t) = ^, and polymer dynamics given by
rV(t)

f°°

rx

y.00

(2.2) + 77 / u(x - y, t)u(y, t)dy - 2t?u(x, t) I u(y, t)dy,
subject to nonnegative initial conditions and the boundary condition

(2.3)
We
Note

u(xo,0=0.

write the polymer lengthening
that in the case u = 0 this is a
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large there is a saturation effect, with the result that less lengthenin
This matches the in vitro observations of [24, 31].

The polymer joining term r\ f* u(x - y, t)u(y, t)dy introduces the join

eter 77 and indicates that a new polymer of length x results from th
smaller polymers of lengths x - y and y. Note that the upper integrat
written as x or x - xq with identical results, as there are zero polyme
than xq. Changing the form of the integration limit does not affect

model. The last term 2r]u(x, t) /^° u(y, t)dy describes the loss of a po
x when it joins with another polymer, of any length, to create a la
Symmetry mandates the factor 2.
Note that with mass action incidence and no polymer joining, i.e
7/ = 0, our model reduces to that in [12, 13, 14, 28]. For this case,
bounded (3(x), /x(x), and a general kernel n(x,y) is analyzed in [32].

2.2. Conversion to ODEs. Under an assumption of equidistribu

a system of three ODEs in V, £/, and P can be obtained from (2.1) an

tributed splitting means that splitting is equally likely wherever two pro
joined together; hence the splitting rate (3(x) is proportional to polymer l

(3(x) = (3x. The accompanying splitting kernel is then

K/T ?,\ - f 1/V if V > xo and 0 < x < y,
MX'^-\ K/T ?,\ - 0 if y<x0 or y<x.

We make the additional assumption that polymer metabolic degra
at a constant rate, i.e., /x(x) = //. A form of the PDEs that assume
and no polymer joining was converted to ODEs in [28] by integr
integrating the product of x and (2.2), over [a:0, 00). Proceeding simila
incidence term is independent of x and converts analogously. The j
f™u(x,t)f™u(y,t)dydx simplifies to U2(t). The remaining joining
(2.2) gives
poo px /.00 px-xo

/ / u(y,t)u(x-y,t)dydx = /

«/£() JXu Jxo JO

/»OO /»OO

= / / u(x - z,t)u(z,t)dxdz
JO Jz+xo
/»OO /»OO

= / / u(w,t)u(z,t)dwdz
Jo Jx0

= u2(t).
The resulting system of equations is

V =/3P-»U- 20xoU - r)U2,

(2-4) v'^X-rV-^p+fi^U,
It is useful to have equations for infectious polymers, noninfectious monomers,
and infectious monomers comprising polymers. To use analysis appropriate for compartmental models, we replace the U equation with an equation for x0U, and the
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y | ^v | /x(x0i/)
Fig. 1. Compartmental diagram of system (2.5).

P equation with an equation for W = P - xqU. The xqU compartment contains all
prpSc unfts that make up the minimum lengths of the polymers. The W compartment

contains all additional PrPSc units. The resulting system of equations is

(x0U)f = (3x0W - n(x0U) - (3xo(xoU) - ^-(x0U)2y
x0

The compartmental diagram of this system appears in Figure 1.

3. Model analysis.

3.1. Nondimensionalization. To facilitate analysis, rewrite the ODE system
(2.5) in a nondimensionalized form. Let a = /i 4- (3xq and T = at. Rewrite U(t) =

*X(T), V(t) = £Ty{T), and W(t) = fTZ(T). Define a = &£, p = a, 6 = &*,

f=^, and<A=f. Then
X' = Z-X-<j)X2,

1 + v\Z + oA; )

with #' = ^ . The nondimensionalization process reduces the number of parameters
from eight to five. Note that 8 = J^*^_ G (0, 1). Setting v = 0 simplifies the incidence
term to mass action, whereas setting 0 = 0 simplifies the model to the case with no
polymer joining.
In all that follows, disease is assumed to be initially present; thus the nonnegative

initial conditions for the nondimensional system are X(Q) > 0, ^(0) > 0, Z(0) > 0,
with X(0) + Z(0) > 0.
Proposition 3.1. Let v,<\> > 0, <r,p > 0, and 6 e (0,1). For each (X(0),y(0),
Z(0)) G R\ the system (3.1) has a unique bounded solution in R+ defined for all
T>0.
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Proof. Let F : R% -> R^. be given by

F((X,y,Z)) = (FuF2,F3)

and observe that F is Lipschitz continuous on bounded sets of R+. For T > 0 and

(A\ y, 2)gR3, it follows that Fi > 0 when X = 0, F2 > 0 when ^ = 0, and F3 > 0

when Z = 0. Thus by Corollary A. 5 in [35] there exists a unique nonnegative solution
to (3.1) in R3 for T G [0,oo). Since

2f(6X(T) + y(T) + Z{T)) = a-(l- 6)SX(T) - Py(T) - (1 - 6)Z(T)
<a- 6{6X{T) + y(T) + 2(T)),
where 0 = min{l - 6, p} > 0, it follows that 6X(T) -f ^(T) + Z(T) < max{f , 6X(0) +
y(0) + -2(0)} = M. Thus the existence of a unique global nonnegative bounded
solution is proved. D

3.2. Computing and interpreting 71q. The disease free equilibrium (DFE)
for this nondimensionalized general model of nucleated polymerization is (X, y, Z) =

(0, ^,0). Note that in the absence of disease, y is stable. The DFE may be used to
fincfthe basic reproduction number llo, which indicates the average number of new
infections caused by a single infective introduced to an entirely susceptible population.

One technique [37] examines the infective compartments, in this case the equations

within (3.1) for X and Z. The Jacobian J of the (X,Z) system about the DFE is
apportioned into two matrices F and G such that J = F - G, where F contains
all elements resulting from new infections and G contains all remaining movement
between compartments. Then 1Z0 is the spectral radius of the matrix FG~l. For the
model given in (3.1),

'■[?:]■ °-[iv].
and the spectral radius of FG~l is ^. Hence 1Z0 = |. The next result follows from
Theorem 2 of [37].
Lemma 3.2. IfH0 < 1, then the DFE of (3.1) is locally asymptotically stable; if
Uq > 1, then the DFE is unstable.
In the biological variables,

<32) k-W^W'

The same 7£0 results from the model of nucleated polymerization in wh

ening mechanism proceeds according to mass action and polymer jo
occur [28]. This result makes it clear that general incidence and joinin
the potential success of infection via nucleated polymerization. How
later, the inclusion of a generalized incidence term and polymer join
the distribution of polymer lengths as time progresses during disea
disease equilibrium.
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3.3. Global stability of the DFE. Assuming that p > 1, the DFE of the
general model of nucleated polymerization given in (3.1) is globally attractive for
llo < 1 and globally asymptotically stable (GAS) for 7£0 < 1. The assumption that
p > 1 is justified biologically; see data in section 4. To show the DFE results, first
consider the model in the case with v = 0, that is, where polymer lengthening occurs
via mass action.

Lemma 3.3. IfU0 < 1, then the DFE (X,y,Z) = (0, ^,0) of the system

X1 = Z-X-<f>X2,
(3.3) y = a - Py - xy + s2x,
z' =xy-z+ 6(j)X2
is globally attractive.

Proof. Consider the Liapunov function

* = \(y-y)2 + h(x + z)
with ki = (2 - 62 - y). Since both 6 < 1 and y = Ko < 1, then fci > 0. This
Liapunov function is the same as that used by [28] for the nondimensionalized model
with mass action and no joining. Its derivative given by

& = -P(y - yf - 0(i _ e)klx2 - X[(y - l)2 + (l - 62)(i - y)]
is nonpositive for 7£o ^ 1- Also $' = 0 only if y = y and X = 0. Thus by LaSalle's

invariance principle [19] the DFE (0, ^,0) of (3.3) is globally attractive. D

Theorem 3.4. Assume p>\. IfU0 < 1, then the DFE (X,y,Z) = (0, ^,0) of

the system (3.1) is globally attractive. IfU0 < 1, then the DFE is GAS.
Proof. From systems (3.1) and (3.3), create the equivalent respective systems

X1 = Z-X-<I)X2,

(3'4) (*A\ Z= 7' X(y + Z)-XZ -2 7^.,y2 + 6<t>*
(3'4) (*A\ Z= 7' l+v(Z + 6X) -2 7^.,y2 + 6<t>* '
(y + Z)' = a - p (y + Z) + (p - \)Z + 62X + 6<t> X2,
and (with v = 0)

X' = Z-X-(j)X2,

(3.5) Z1 = X(y + Z)-XZ-Z + 6<t> X2,
(y + zy = a - p(y + z) + (p - \)z + s2x + 6$ x2,

subject to the same nonnegative initial conditions. Since p > 1, system
K-monotone. Then v > 0, 6 e (0, 1), X > 0, and Z > 0 imply by a stand

comparison theorem given in [34, Appendix Bl] that (X, Z,y + Z)(3A) < (X,
2)(3.5). Let T^o < 1. Since by Lemma 3.3, the DFE of (3.5) is globally attract
by Proposition 3.1, X > 0 and Z > 0, it follows that X -> 0 and Z -> 0 for sy
(3.4). From the second equation of (3.1), the theory of asymptotically auto
systems [6] shows that y - > |. The global asymptotic stability result then

from Lemma 3.2. D

In order to use the comparison theorem to show that the DFE of sys
GAS, it is required that p > 1 in Theorem 3.4. Next we apply the Liapu
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to establish that the DFE is GAS without assuming that p > 1 but at
required to be less than 1 - 62.

Theorem 3.5. The DFE of system (3.1) is GAS if Ho <l-62.

Proof Define

$ = y-y]n(y/y) + z + x.
Notice that o = py. The derivative of $ along the solution of system (3.1) is
given by

< -P{y ~ ^ - (i - W*2 - <>2y^ + x (s2 + y - 1) .
This shows that $' is nonpositive for Kq = £ = y < 1 - 62 and $' = 0 only if
y = y and X = 0. Again, by LaSalle's invariance principle and Lemma 3.2, the DFE
is GAS. D

3.4. Existence and stability of the EE. We now consid

librium (EE) with disease present, i.e., X > 0, y > 0, Z > 0.

Lemma 3.6. IfH0 > 1, then system (3.1) has a uniqu

mat that tsb EE ?«j is given nivpn hn 0y ( (X X* ,y V* ,£ 7*\ ) - -

mat that tsb EE is ?«j given nivpn 0y hn (X ( X* ,y V* ,£ 7*\ ) - - ^px/(1+6)+r(1_^), a~p pl/(1+6)+(1_6i}, pi/{1+S)+(i-6*) g-p ) -

IfU0<l, then (3.1) has no EE.

Proof If (j) > 0, then system (3.1) cannot be solved explicitly for the EE. However,
for 4> > 0, at equilibrium, Z and y can be expressed in terms of X by

Z = X + <$>X2,

(3.6) y=i[j-x(l + 4>X) + 6X((j>X + (5)]
= [1 + i/AT(l + 6 + 0*)] [1 + <t>X{l - 6)} ,
and X satisfies the cubic equation
0 = pv<t>2(\ - 6)X3 + [pv<\> + pv4>(\ - 62) + 0(1 - 6)] X2

(3.7) + [pu{\ +6)+ p<t>{\ - 6) + (1 - <52)] * + p - a.
Since the first three coefficients of (3.7) are positive and the constant term is negative

for 1Zo > 1, there is a unique positive root. The expressions in (3.6) show that unique
positive equilibrium values for y and Z result from the unique positive X\ hence

there is a unique EE (X*,y\Z*) for Uq > 1. If 0 = 0, then the solution of (3.7) is
given explicitly as X* = pi/(l^)~/(i-6^)^ givinS ^* and Z* from (3.6) as in the lemma
statement. If TIq < 1, then (3.7) has no positive root, and hence there is no EE. D
The proof of the following result is standard, using the Routh-Hurwitz conditions.

For details, see Appendix A.

Theorem 3.7. IfUo > 1, then the unique EE of system (3.1) is locally asymp-

totically stable.

Remark 3.8. If Hq > 1 and p > 1, then every solution of (3.1) approaches either

the EE or the DFE.
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Proof. Consider the equivalent system {X,Z,y + Z) of (3.1), namely (3.4). Th
equivalent system's matrix of partial derivatives has the sign pattern
" - + 0 "
+ - +

in the case when p > 1 (where * is + o

tive system. Then by Theorems 2.3.2 and
[33], the system exhibits monotone dyna
equilibrium. □

The system equivalent to (3.1) has only two possible equilibria: the DFE (0, 0,
and the EE {X*,Z*,y* + Z*) from Lemma 3.6. If 1ZO > 1, then by Lemma 3.2, the
DFE is unstable, and by Theorem 3.7, the EE is locally asymptotically stable. The
facts together with numerical simulations (see section 4) indicate that the EE is G
if 72,o > 1 and p > 1, but we do not have a proof.
A Liapunov function argument is used in section 3.4 of [28] to prove a global
asymptotic stability result in the case u = 7? = 0.
3.5. Effects of v and <f> on the EE. The nucleated polymerization model
with mass action and without polymer joining has been well studied in earlier work
[12, 13, 14, 28]. It is useful to understand the effects of positive values of v and <j>
on the EE of model (3.1). By taking partial derivatives of (3.6) and (3.7) and using
parameter relationships at the EE, the following signs are determined. (For selected
details, see Appendix B.)

Proposition 3.9. At the EE of (3.1), for Hq > 1, ^ < 0, ^ > 0, and

Proposition 3.10. At the EE o/(3.1), for Uo > 1, ^- < 0 and ^ > 0.
3.6. Summary of ODE results for biological variables. The previous results
are now summarized in terms of the original biological variables in system (2.5). Recall

that X, y, and Z in (3.1) are respectively proportional to xqU (the number of PrPSc
units in the minimum lengths of the polymers), V (the number of PrPc monomers),
and W (the PrPSc units not accounted for within the minimum lengths of the polymers), all satisfying system (2.5). With nonnegative initial conditions, system (2.5)
has a unique bounded solution in R+ defined for all t > 0. The basic reproduction

number 1Z0 is given by (3.2). The DFE (x0U, V, W) = (0, ^,0) is globally attractive
if 7 > /3x0 + \i and Hq < 1 and is GAS if 1Z0 < 1. If Ho > 1 and 7 > (3x0 + //, then
the unique EE (#ot/*, V*, W*) demonstrated in Lemma 3.6 is locally asymptotically

stable in R% \ [{0} x R+ x {0}]. For 1Z0 > 1, at the EE, d{x^] < 0, $£- > 0,
TC1 < °> d{XdT] < °' and %- >0' The siSn of ^F is undetermined in general,
since the sign of ^- is unknown.
We can also interpret the results in terms of P (the number of PrPSc monomer

units comprising the polymers) from (2.4). At the DFE, P = 0, and at the EE,
P* = W* + XoU*. By adding the second and third equations in (2.4), it follows
that ^- < 0 and ^^ < 0 at the EE. The ratio ^ gives the mean polymer length.
Dividing the last equation of (2.4) by U and differentiating with respect to 77, it is

seen that ^(^-) > 0 at the EE.
3.7. A solution of the PDE system in the case of general incidence.
Returning to (2.1) and (2.2), consider the case of general incidence but no joining,
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i.e., rj = 0. The corresponding system of ODEs given in system (2.4
7/ = 0, has EE from Lemma 3.6 given by the following:
/3703*q + /z)2-/?2At
(2/3xo + l*)[un(0xo + /i)2 + 0ht] '

/» R, v. = {pxo + n)2(u\ + n)

( R, ' v. = w7(/3x0 + m)2H-/3/xt'
p._ l(0xo + h)2-(3\t
wy(/3x0 + fi)2 + Put'

To find an equilibrium distribution of polymer lengths, set J^u(x,
Compute the derivative with respect to x of the rest of (2.2), subst
of U*,V*, and P* from (3.8) to obtain

The boundary condition u(x0) = 0, first given in (2.3), can be used to
to (3.9) of the form

(3.10) u(x) = Ce W'o+i*)* (z-zo)(/?z + /3xo + 2^).
Note that from (2.2) with x = xo,

(3.11) |Wl)] = W.(il^l).
Substitute into (3.11) values of £/*, V*, and P* from (3.8). Then compute the derivative of (3.10) and set it equal to (3.11) to find
/?3(/?AT-7(/?*o + /i)2)

(0xo + /i)3(2/3x0 + /i)ky03xo + A*)2 + /*/?r

The equilibrium solution from (3.10), denoted by ti*

/ fl(«-«n)(fl«+fl*o+3/o\ /33(x - xQ)(/3x -h /3x

(3.12) «-(x)=^e ^.-> j {/3xo + M)3(2/3

where 7^0 is given in (3.2). Note that the numerato
Hq > 1. The denominator of u*(z) shows that an incre
of polymers of length x at steady state for all viable
Prom (3.10), it can be seen that the value of x at w
mum is independent of u and is given by

(3.13) x = (VS - 1)^ + VZx0

However, from (3.12), the magnitude of this maxim
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Fig. 2. Varying lj = 0, 10"5, 10"4, 10"3, 10"2 for populations U(t), V(t), andP(t) withxo
A = 4400, 7 = 5, r = 0.3, /x = 0.04, j3 = 10~4, n = 0. Range of lj runs top to bottom on U
graphs, bottom to top on V graph.
U*
0.5

1

0.45 f\

0.4 If \\
0.35 ■ I \

0.3 // ^

0.25 / /~\ \

0.2 / / \ \

0.15 // \ \
0.05 # /"

°0 = 500 1000 1500 2000

Fig. 3. Steady-state polymer distribution u*(x) with xo = 6, A = 4400, 7 = 5, r = 0.3,

/i = 0.04, /3 = 10~4, 77 = 0, and lj = 0, 10"5, 10~4, 10"3, 10~2. Range of lj runs from top cur
bottom on graph.

4. Numerical simulations. To complement the previous analytical results, w
present some numerical simulations. All simulations shown, unless otherwise n

use the same parameters as in [14], namely xq = 6/(SAF/sq), A = 4400/day
5/day, r = 0.3/(SAF/sq * day), \i = 0.04/day, and 0 = 10"4(SAF/sq)/day, g
p«2x 105 > 1. These parameters follow from data and observations in [3, 7
25, 30]. Some broader ranges include that x0 « 6-30 [20], PrPc has a half-li
3-6 hours [3, 7, 25] and hence 7 « 3-5/day, \x < 7 [20, 25], and A » 103-104

[20]. The units SAF/sq are a measure of scrapie-associated fibrils counted in sple
Compton white mice that had been given intracerebral injections of the 139A sc
strain [30]. Note that the above parameter set gives 7£o » 16. We vary values
and rj to investigate the changes introduced by these parameters.
First consider general incidence. The effects of the parameter u on £/, V , an
discussed in section 3.6, are shown in Figure 2. Additionally, the equilibrium sol
for u(x) found in (3.12) allows a comparison of steady-state polymer distribut
given differing values of u. This appears in Figure 3, computed from (3.12). N
that, for all values of a;, the maximum value of u(x) occurs at x « 303, as can
computed from (3.13).
Next consider joining. Section 3.6 describes the effects of 77 on the EE of sy
(2.4), shown numerically in Figure 4. As discussed in section 3.6, the sign of @£

undetermined; hence the sign of ^-p is also undetermined. It turns out that m

parameter combinations, but not all, support ^- < 0. The opposite can occur in
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250,
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Fig. 4. Varying rj = 0, 10"4, 10"3, 10"2, 10"1 for populations U(t), V(t), and P(t) w
A = 4400, 7 = 5, r = 0.3, /x = 0.04, 0 = 10~4, w = 0. Range of rj runs top to bottom

graphs, bottom to top on V graph.
W

210500 /^ "^\^^

210000 ^v

209500 ^^^^^
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208500

s.

^V

0.00002 0.00004 0.00006 0.00008 0.0001

Fig. 5. Dependence of W* on n with x0 = 6, A = 4400, 7 = 5, r = 0.3, /x = 0.02
u> = 0.

case that 6 - ♦ 1, which is possible in the case that /x is small or (3xo is large. A brief

explanation appears in Appendix C. Even so, it appears that ^- > 0 for only small
values of (f). This effect is demonstrated in Figure 5 for ^^ , which is proportional

to ^- > 0. The parameters used in Figure 5 are the same as those listed above, but
with smaller /i, namely \i = 0.02, and u = 0.

Last, combine general incidence with joining. Lemma 3.2, Theorem 3.7, and
Remark 3.8 together suggest that the EE of system (3.1) is GAS. Numerical simulations such as those shown in Figure 6 support this suggestion. The pair of surfaces
in this figure show long-term equilibrium values of U and P, denoted C/qq and P^, as
both u and 77 vary. For all shown pairs of u) and rj values, both Uqq and P^ remain
positive, indicating (as a consequence of Remark 3.8) that they correspond to U* and
P*. The shown ranges for u and rj correspond to the lower range of values used in
Figures 2, 3, 4, and 5. Similar graphs generated using higher values of lj and rj also
result in positive values of £/qo and Poo- The parameter values used for xo, A, 7, r, /i,

and /? are the same as those given at the beginning of this section.
Figures 2, 3, and 4 were computed using MATLAB, with odel5s for Figures 2
and 4. Figures 5 and 6 were computed using Mathematica.

5. Biological interpretation and discussion. We now discuss the analytical
results and numerical simulations (for the assumed parameter values) in terms of prion

biology. From sections 3.2 and 3.3, the system (2.4) always has a DFE (£/, V, P) =

(0, ^,0), which attracts all solutions if 7 > /i + (3 * x0 and 1Z0 = ^fj^^ < 1. This

is the only equilibrium for 7£0 < 1, but for Ho > 1 there is a unique EE ([/*, V*, P*),
with P* = W* 4- xqU* and V* < A/7, as can be seen from (3.6). This equilibrium
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Fig. 6. Long-term values Uoo and Poo as r\ and uj vary. In both gmphs xq = 6, A = 4400,

7 = 5, t = 0.3, \i = 0.04, and (3 = 10~4. On the U^ graph, 10"6 < r/ < 10"3, 10~6 < u> < 10"
and 50 < C/oo < 250. On the Poo graph, 10~6 < r\ < 10~2, 10~6 < a; < 10~4, and 20,000 < Poo
100,000.

is given explicitly by (3.8) in the case of no joining, and with joining it can be fou

from the solution of a cubic (see Lemma 3.6). If 1Zo > 1, then this EE is loca

asymptotically stable.
Prom section 3.6, both increased u and increased rj cause U* to decrease. The

change related to u indicates that as the total population of PrPSc has a grea
effect on general incidence, the total number of polymers at the EE decreases. F
the parameters used, if u> > 10~3, then the values of ([/*, V*, P*) are close to those
the DFE, as seen in Figure 2. The change related to 77 indicates that a higher rate
polymer joining results in fewer total polymers at the EE. Increased u and increa
77 cause V* to increase. Hence the same biological changes cause both a decrease
prpSc poivmers anci an increase in PrPc at the EE. Additionally, increased u and
increased rj cause the equilibrium value P* of total PrPSc to decrease. If 77 increa
then at the EE the mean polymer length ^ increases, with lnP* decreasing more
slowly than In U* .

The effects on W* are more complicated. Increased a;, that is, increased depe
dence of incidence on the total PrPs<r^>opulation, decreases W*. On the other han
an increased rate of polymer joining has a variable effect on W*. Differing parame
combinations can cause W* to either increase or decrease with a positive change
T)\ see Figure 5. That noted, it is also true that most viable parameter combinatio
cause W* to decrease when 77 increases.

Recall that the form of TZo given in (3.2) is the same with either mass action or ou

general incidence term, and with or without polymer joining. Despite the inabil
of lj and 77 to affect disease persistence, however, each of these parameters has
demonstrable effect on the steady-state values of £/, V, and P. Also, increasing
clearly decreases the number of polymers of each possible length, with the maxim

for u = 10~4 being about half the maximum for u = 0; see Figure 3. From d

given by Rubenstein et al. [30], the onset of symptoms of scrapie can be estima
[14] to occur as U(t) reaches a critical value of 130 SAF/sq. From Figures 2 and 4
the inclusion of general incidence or joining may result in U* less than this criti
value, while V* remains closer to its DFE value. Thus, if the effects of prion dise
are caused by either an excess of PrPSc or a lack of PrPc [24, 29], then changing
the EE by increasing u or 77 may be enough to delay or prevent the onset of dise
symptoms.
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Appendix A. Proof of Theorem 3.7. Consider a system equivalen

namely, the system given by (3.4). Setting each of the derivatives to zero

Z*=** + 0(**)2,

l + v{Z*+6X*)=1 + iK1-S)X-

Set q = 1 + </>(l - S)X* and r = 1 + */**(l + 6 + 0**). Then the Jacob
at the unique EE is given by

-1-20**
r

1

r

0
r

<52 + 20<5** p - 1 -p m
The Jacobian yields the characteristic equation

z3 +cxz2 + c2z + c3 = 0
with

c2 = ^(1 - «) + 2p(l + ^') + [2(l + W + (,+ l^ +
r

--r (62 + 2^^*).
Notice that 0 < 6 < 1 and <V* > 0 when Uo > 1. Clearly ci > 0 and c2 > 0.
Additionally,

c3 > (1 + 20**) (p + ^pj - p(l + 0(1 + 6)**) - ^(62 + 20(5**) > 0.
Rewriting C3 as

c3 = - [1 +r
20** - ((52 +r
206**)] + £02*1(1 + 20** + «) + p0**(l - 6),
it can be shown that

ci c2 > -(2
+ 20**)
+ £^1{2 + 20**) + p(2 + 20**) > c3.
r
r
Hence

the

Appendix B. Selected proofs of Propositions 3.9 and 3.10. Differentiate
(3.7) implicitly to give ^- < 0, then compute from (3.6) that
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Differentiate (3.7) implicitly to obtain
dX*

_

d<t>

~

3i/p02(l

which

-

shows

6)(X*)2

that

+

^-

2[vp4>

<

0.

+

i/p*(l

Next

com

Substitute $£- from above, and wri
inator. The resulting numerator can

vp<t>2{\

+
The

i/p(l

-

-

numerator

Appendix
expressions

8)(X*)4

+

S2)(l

8){X*)2

is

C.

+

seen

2*/p<Kl

to

be

X*

and

Z*

p(

strictly

Computing

for

+

-

valu

in

(3.6

dX* -(X*)2
~W > 2<t>X* + V
where ^- is given by
dX*

~&P~ ~

Letting 6«1,

Hence for 6 near 1, there are likely to be ranges of </> values for which
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